Jennifer Browning, MD
Obstetrics & Gynecology · Humble, TXNPI 1003898354
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $17,864 of the $25,090 with a category attached, or 71.2%. 33 manufacturers reported payments, led by Merz North America, Inc. at 44.1% of the total. Reporting peaked in 2022 at $6,138 and has fallen 80.4% since, to $1,205 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 411 payments — averaging $61.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$11K
- AbbVie$11K
- Revance Therapeutics, Inc.$1K
- Galderma Laboratories, L.p.$613
- Bayer$172
- Mayne Pharma Commercial LLC$145
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$7,20229%
- Food & beverage$17,86471%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 62 | $11,059 |
| AbbVie(2 entities) | 204 | $10,854 |
| Revance Therapeutics, Inc. | 15 | $1,071 |
| Galderma Laboratories, L.p. | 37 | $613 |
| Bayer | 8 | $172 |
| Mayne Pharma Commercial LLC | 5 | $145 |
| Lupin Inc. | 13 | $125 |
| Coopersurgical, Inc. | 7 | $104 |
| Merck | 7 | $91 |
| Therapeuticsmd, Inc. | 4 | $81 |
| Hologic Sales And Service, LLC | 5 | $80 |
| Organon | 11 | $77 |
| Johnson & Johnson | 3 | $66 |
| Astellas Pharma US Inc | 3 | $62 |
| Exeltis, USA Inc. | 4 | $59 |
| Avion Pharmaceuticals | 3 | $44 |
| Zimmer Biomet | 1 | $41 |
| Biogen | 2 | $37 |
| Boston Scientific | 2 | $37 |
| Agile Therapeutics, Inc. | 2 | $30 |
| Myovant Sciences Inc. | 1 | $26 |
| Acessa Health Inc. | 1 | $24 |
| Shield Therapeutics Inc | 1 | $24 |
| Medtronic | 1 | $24 |
| Intuitive Surgical | 1 | $21 |
| Biom'up France SAS | 1 | $20 |
| Millicent US Inc | 1 | $18 |
| Davol Inc. | 1 | $15 |
| BD | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,090 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 13 | $665 |
| Estradiol | 17 | $631 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Humble
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.